l-carnitine tmao koeth 2013 nature medicine γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to l carnitine tmao nature medicine
l carnitine tmao nature medicine 2013 koeth Gut microbiota metabolism of l carnitine and cardiovascular risk Dietary allicin reduces transformation of Frontiers TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans Gut Microbiota Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? Trimethylamine Noxide: breathe new life Subramaniam 2018 British Journal of Pharmacology Wiley Online Library
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




